IVITF: Invictus MD Strategies (CNSX:IMH) Analysis and Research Report

2017-12-18 - by Asif , Contributing Analyst - 159 views

Important Note
Fintel Research Reports are free Wikipedia-style reports that are created and edited by people just like you. If you are an expert on a company and would like to help your fellow investors make more informed investing decisions, then you should become a Fintel Contributing Analyst. To do this, register on the site, message us in the online chat, and we will get you started.

Invictus MD is a cannabis company founded in Vancouver, Canada. Invictus MD went public December 2014. The company represent a platform of licensed producers, under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), dedicated to providing high-quality, regulated pharma-grade cannabis for medical and recreational use. The company's growers are supported by over 250 acres of buildable property with full access to its team of industry-leading horticulturists, biochemists, and project managers.

Production update

Acreage Pharms Ltd - West-Central, Alberta

Phase 1 - Existing

  • 6,800 sq ft purpose built concrete and steel facility
  • 609 kg cannabis cultivation capacity per annum
  • Level 8 vault allows for storage onsite of $31.25MM of dried cannabis
  • The current 150-acre property can accommodate future expansion plans
  • Invictus MD owns 100% of Acreage Pharms

Phase 2 - Funded Expansion

  • 32,000 sq ft purpose built concrete and steel facility
  • 4,391 kg cannabis capacity per annum
  • Purpose built concrete and steel facility
  • Level 8 vault will allow for storage onsite of $31.25MM of product
  • $6.0MM Project
  • Permitted, construction in progress - expected completion by January 2018
  • Fully funded

Phase 3 - Expansion

  • 76,750 sq ft purpose built concrete and steel facility
  • 9,000 kg cannabis cultivation capacity per annum
  • $16.5MM Project expected to be completed by June 2018 - subject to permitting
  • Fully funded

AB Laboratories Inc. - Hamilton, Ontario

  • 16,000 sq ft purpose built concrete and steel facility
  • 1,000 kg cannabis cultivation capacity per annum
  • Actively seeking adjoining properties for direct expansion to the existing facility
  • Invictus MD owns 33 1/3 of AB Laboratories Inc.

Phase 1 - Funded Expansion

  • 21,000 sq ft expansion plan is expected to be completed by the end of 2017 with an additional 21,000 sq ft building envelope
  • 3,000 kg cannabis cultivation capacity per annum
  • Purpose built concrete and steel facility
  • $5.5MM projected cost for Phase 1 expansion
  • Fully funded subject to permitting

Production Forecast

YearAcreage Pharms (kg)AB Labs (kg)AB Ventures (kg)Total (kg)
2017502500300
20183,8501,0003,0007,850
20198,0001,0008,00017,000
202015,0001,00015,00031,000
202125,0001,00024,00050,000


Comments

Add a Comment